1. Home
  2. NVAX vs KOS Comparison

NVAX vs KOS Comparison

Compare NVAX & KOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • KOS
  • Stock Information
  • Founded
  • NVAX 1987
  • KOS 2003
  • Country
  • NVAX United States
  • KOS United States
  • Employees
  • NVAX N/A
  • KOS N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • KOS Oil & Gas Production
  • Sector
  • NVAX Health Care
  • KOS Energy
  • Exchange
  • NVAX Nasdaq
  • KOS Nasdaq
  • Market Cap
  • NVAX 2.0B
  • KOS 1.7B
  • IPO Year
  • NVAX 1995
  • KOS 2011
  • Fundamental
  • Price
  • NVAX $8.47
  • KOS $4.03
  • Analyst Decision
  • NVAX Buy
  • KOS Buy
  • Analyst Count
  • NVAX 6
  • KOS 4
  • Target Price
  • NVAX $17.83
  • KOS $5.75
  • AVG Volume (30 Days)
  • NVAX 5.8M
  • KOS 8.9M
  • Earning Date
  • NVAX 11-12-2024
  • KOS 11-04-2024
  • Dividend Yield
  • NVAX N/A
  • KOS N/A
  • EPS Growth
  • NVAX N/A
  • KOS 176.13
  • EPS
  • NVAX N/A
  • KOS 0.45
  • Revenue
  • NVAX $885,193,000.00
  • KOS $1,785,713,000.00
  • Revenue This Year
  • NVAX N/A
  • KOS $4.20
  • Revenue Next Year
  • NVAX N/A
  • KOS $16.69
  • P/E Ratio
  • NVAX N/A
  • KOS $8.94
  • Revenue Growth
  • NVAX N/A
  • KOS 4.61
  • 52 Week Low
  • NVAX $3.53
  • KOS $3.49
  • 52 Week High
  • NVAX $23.86
  • KOS $7.07
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 41.69
  • KOS 52.43
  • Support Level
  • NVAX $6.81
  • KOS $3.87
  • Resistance Level
  • NVAX $10.39
  • KOS $4.22
  • Average True Range (ATR)
  • NVAX 0.66
  • KOS 0.21
  • MACD
  • NVAX 0.09
  • KOS 0.04
  • Stochastic Oscillator
  • NVAX 46.37
  • KOS 73.29

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About KOS Kosmos Energy Ltd. (DE)

Kosmos Energy Ltd is an independent oil and gas exploration and production company focused on frontier and emerging areas along the Atlantic Margin. The company focuses on field developments designed to accelerate production. Kosmos' exploration is tied to a geologically based approach geared toward the identification of petroleum systems. Its process starts with geologic studies that assess a region's subsurface but also incorporates basin modeling as well as techniques to identify reservoir/seal pair development and trap definition. In addition, a 3D seismic analysis is done to identify prospective traps of interest. In tandem with the subsurface analysis, a country-specific analysis is done to get an understanding of above-ground dynamics before targeting specific licenses.

Share on Social Networks: